Clinical Laboratory Improvement Amendments
From Wikipedia, the free encyclopedia
| This standards- or measurement-related article is a stub. You can help Wikipedia by expanding it. |
Clinical Laboratory Improvement Amendments (CLIA) are United States federal regulatory standards[1] that aply to all clinical laboratory testing performed on humans in the United States, except clinical trials and basic research. CLIA define a clinical laboratory as any facility which performs laboratory testing on specimens derived from humans for the purpose of providing information (1) for the diagnosis, prevention, or treatment of disease or impairment, and (2) for the assessment of health. An objective of the CLIA is to ensure the accuracy, reliability and timeliness of test results regardless of where the test was performed.
Contents |
The United States Congress passed the CLIA in 1988.
In accord with the CLIA, the CLIA Program[2] sets standards and issues certificates for clinical laboratory testing.
Centers for Medicare and Medicaid Services (CMS), formerly the Health Care Financing Administration, assumes primary responsibility for the operation of the CLIA Program. Within CMS, the Center for Medicaid and State Operations, Survey and Certification Group, Division of Laboratory Services implements the program.
The CLIA Program is funded by user fees collected from approximately 189,000 laboratories[3], most located in the United States.